Coya Therapeutics, Financials
| COYA Stock | 6.51 0.17 2.54% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.94 | 11.5855 |
|
|
Investors should never underestimate Coya Therapeutics,'s ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Coya Therapeutics,'s cash flow, debt, and profitability to make informed and accurate decisions about investing in Coya Therapeutics, Common.
Net Income |
|
Coya | Select Account or Indicator |
Understanding current and past Coya Therapeutics, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Coya Therapeutics,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Coya Therapeutics,'s assets may result in an increase in income on the income statement.
Please note, the presentation of Coya Therapeutics,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Coya Therapeutics,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Coya Therapeutics,'s management manipulating its earnings.
Coya Therapeutics, Stock Summary
Coya Therapeutics, competes with Cue Biopharma, Lantern Pharma, Fennec Pharmaceuticals, Acumen Pharmaceuticals, and Inozyme Pharma. Coya Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US22407B1089 |
| CUSIP | 22407B108 |
| Location | Texas; U.S.A |
| Business Address | 5850 San Felipe |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.coyatherapeutics.com |
| Phone | 800 587 8170 |
Coya Therapeutics, Key Financial Ratios
| Return On Equity | -0.4 | ||||
| Price To Sales | 31.29 X | ||||
| Revenue | 3.55 B | ||||
| Gross Profit | (8.31 M) | ||||
| EBITDA | (17.22 M) |
Coya Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Coya Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Coya Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Coya Therapeutics, competition to find correlations between indicators driving Coya Therapeutics,'s intrinsic value. More Info.Coya Therapeutics, Common is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Coya Therapeutics,'s Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Coya Therapeutics,'s earnings, one of the primary drivers of an investment's value.Coya Therapeutics, Common Systematic Risk
Coya Therapeutics,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Coya Therapeutics, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Coya Therapeutics, Common correlated with the market. If Beta is less than 0 Coya Therapeutics, generally moves in the opposite direction as compared to the market. If Coya Therapeutics, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Coya Therapeutics, Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Coya Therapeutics, is generally in the same direction as the market. If Beta > 1 Coya Therapeutics, moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Coya Therapeutics, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Coya Therapeutics,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Coya Therapeutics, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Coya Therapeutics, March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Coya Therapeutics, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Coya Therapeutics, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Coya Therapeutics, Common based on widely used predictive technical indicators. In general, we focus on analyzing Coya Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Coya Therapeutics,'s daily price indicators and compare them against related drivers.
| Downside Deviation | 3.84 | |||
| Information Ratio | 0.0733 | |||
| Maximum Drawdown | 20.41 | |||
| Value At Risk | (5.84) | |||
| Potential Upside | 7.2 |
Complementary Tools for Coya Stock analysis
When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |